Highly active disease-modifying therapy initiation patterns in multiple sclerosis patients during the Covid19 pandemic: the Royal Free London NHS Trust experience


By Dr Charmaine Yam, Neurology Clinical Fellow, Royal Free London NHS Foundation Trust

Poster

Write up

More MS Academy Medication Projects

Experience with Cladribine in RRMS patients at Lancashire Teaching Hospitals NHS Foundation Trust
By Dr Suhaib Mohammed, specialty registrar neurology, Lancashire Teaching Hospitals NHS Foundation Trust
Evaluating the need for routine testing and antibiotic use in patients receiving Ocrelizumab
By Evaluating the need of routine testing and antibiotic use in patients receiving Ocrelizumab
Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.